FDA Inspection 1035085 — Debra J. Kelsh, MD
The FDA completed an inspection of Debra J. Kelsh, MD on November 21, 2017 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Overland Park, KS (United States)
Additional Details
Clinical Investigator (CI)